Voluntary batch recall for Taxotere Concentrate for solution for infusion 20 mg/ml and 80 mg/4ml (SIN14106P, SIN14107P)

Sanofi-Aventis Singapore Pte. Ltd. has issued a Dear Healthcare Professional Letter to inform healthcare professionals of a voluntary recall for selected batches of Taxotere Concentrate for solution for infusion 20 mg/ml (SIN14106P) and Taxotere Concentrate for solution for infusion 80 mg/4ml (SIN14107P). A failure in the filling process has led to a low number of potentially over-concentrated Taxotere Concentrate vials. As a precautionary measure, Sanofi has initiated the voluntary recall of these affected batches. As a consequence, a risk of shortage is anticipated. Healthcare providers should carefully monitor patients for signs of toxicity and treat appropriately. In case of a shortage, patients previously treated with Taxotere should preferably be switched to an alternative. Please refer to the letter for details.

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg ↗ (opens in new tab) and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under ‘For Healthcare Professionals’.

Step 2: Click on ‘Useful links’.

Step 3: Click on ‘MOH Alert’ and log in via Singpass.

Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.